Your browser doesn't support javascript.
loading
Implementation of CYP2D6 copy-number imputation panel and frequency of key pharmacogenetic variants in Finnish individuals with a psychotic disorder.
Häkkinen, Katja; Kiiski, Johanna I; Lähteenvuo, Markku; Jukuri, Tuomas; Suokas, Kimmo; Niemi-Pynttäri, Jussi; Kieseppä, Tuula; Männynsalo, Teemu; Wegelius, Asko; Haaki, Willehard; Lahdensuo, Kaisla; Kajanne, Risto; Kaunisto, Mari A; Tuulio-Henriksson, Annamari; Kampman, Olli; Hietala, Jarmo; Veijola, Juha; Lönnqvist, Jouko; Isometsä, Erkki; Paunio, Tiina; Suvisaari, Jaana; Kalso, Eija; Niemi, Mikko; Tiihonen, Jari; Daly, Mark; Palotie, Aarno; Ahola-Olli, Ari V.
Afiliación
  • Häkkinen K; Department of Forensic Psychiatry, Niuvanniemi Hospital, University of Eastern Finland, FI-70240, Kuopio, Finland. katja.hakkinen@niuva.fi.
  • Kiiski JI; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, FI-00014, Helsinki, Finland. katja.hakkinen@niuva.fi.
  • Lähteenvuo M; Department of Clinical Pharmacology, University of Helsinki, FI-00014, Helsinki, Finland.
  • Jukuri T; Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, FI-00014, Helsinki, Finland.
  • Suokas K; Department of Forensic Psychiatry, Niuvanniemi Hospital, University of Eastern Finland, FI-70240, Kuopio, Finland.
  • Niemi-Pynttäri J; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, FI-00014, Helsinki, Finland.
  • Kieseppä T; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, FI-00014, Helsinki, Finland.
  • Männynsalo T; Department of Psychiatry, University of Oulu, FI-90014, Oulu, Finland.
  • Wegelius A; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, FI-00014, Helsinki, Finland.
  • Haaki W; Tampere University, FI-33014, Tampere, Finland.
  • Lahdensuo K; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, FI-00014, Helsinki, Finland.
  • Kajanne R; Social Services and Health Care Sector, City of Helsinki, FI-00099, Helsinki, Finland.
  • Kaunisto MA; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, FI-00014, Helsinki, Finland.
  • Tuulio-Henriksson A; University of Helsinki, Helsinki University Hospital, Psychiatry, FI-00029, Helsinki, Finland.
  • Kampman O; Mental Health Unit, Finnish Institute for Health and Welfare, Helsinki, FI-00271, Finland.
  • Hietala J; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, FI-00014, Helsinki, Finland.
  • Veijola J; Social Services and Health Care Sector, City of Helsinki, FI-00099, Helsinki, Finland.
  • Lönnqvist J; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, FI-00014, Helsinki, Finland.
  • Isometsä E; University of Helsinki, Helsinki University Hospital, Psychiatry, FI-00029, Helsinki, Finland.
  • Paunio T; Mental Health Unit, Finnish Institute for Health and Welfare, Helsinki, FI-00271, Finland.
  • Suvisaari J; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, FI-00014, Helsinki, Finland.
  • Kalso E; Department of Psychiatry, University of Turku and Turku University Hospital, FI-20521, Turku, Finland.
  • Niemi M; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, FI-00014, Helsinki, Finland.
  • Tiihonen J; Mehiläinen, FI-00260, Helsinki, Finland.
  • Daly M; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, FI-00014, Helsinki, Finland.
  • Palotie A; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, FI-00014, Helsinki, Finland.
  • Ahola-Olli AV; Department of Psychology and Logopedics, Faculty of Medicine, University of Helsinki, FI-00014, Helsinki, Finland.
Pharmacogenomics J ; 22(3): 166-172, 2022 05.
Article en En | MEDLINE | ID: mdl-35197553
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Citocromo P-450 CYP2D6 Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Pharmacogenomics J Asunto de la revista: BIOLOGIA MOLECULAR / FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Finlandia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Citocromo P-450 CYP2D6 Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Pharmacogenomics J Asunto de la revista: BIOLOGIA MOLECULAR / FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Finlandia